The Georg-Speyer-Haus participates in a new EU Research consortium


The EUbOPEN consortium (Enabling and Unlocking Biology in the OPEN) aims to generate a comprehensice open access library of pharmacologic compounds. The EU-project will be funded for 5 years by the Innovative Medicines Initiative (IMI2) and represents a collaboration between 22 academic and pharmaceutical companies. At the Georg-Speyer-Haus drug screening assays using patient-derived cells will be performed.

Detailed information can be found on the page of EUbOPEN.